Serum Institute Awaiting Gavi Push For $2 Pneumococcal Vaccine

Pricing Comes Close To MSF’s $5 A Course Target

Serum Institute hopes to hear by May from Gavi on whether it will consider the firm's $2 per dose pneumococcal conjugate vaccine for immunization programs across developing countries. Its 10-valent vaccine, versus GSK’s 11-valent and Pfizer’s 13-valent vaccines, is 30% cheaper.

Vaccination
Serum First Indian Company To Develop Pneumococcal Vaccine • Source: Shutterstock

Serum Institute of India Ltd., a global producer of vaccines, hopes to hear from Gavi, the vaccine alliance, by May this year on whether its $2 alternative to existing pneumococcal conjugate vaccines (PCV) which cost $3 per dose, will be considered for inclusion in its immunization programs.

“We have submitted everything required and between one to three months, we should come to know if we will get...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip